Ms. Kim Boericke
President of ICON Commercialisation & Outcomes Services
Ms. Kim Boericke is President of ICON Commercialisation & Outcomes Services, having previously served as EVP Global Program Management, where she was responsible for a number of therapeutic units (Oncology, Cardiovascular/Metabolic Diseases, CNS and Aging Diseases, Rare Diseases, Infectious Disease and Vaccines, Internal Medicine and Immunosciences, and Biosimilars). Prior to joining ICON, Ms. Boericke has held positions with several clinical research organisations (CROs), including ClinTrials, Quintiles, INC Research, Duke Clinical Research Institute, and i3. Ms. Boericke graduated with a Batchelor of Science degree from Duke University in 1989.